Gumustepe, E. Et Al. 2021. The Relation of miRNA21/155 levels with acute side effects and treatment response in stage III NSCLC. RADIOTHERAPY AND ONCOLOGY .

Gumustepe, E., Kaplan, I., Baysan, C., KARABULUT, H. G., Birgi, S., & AKYÜREK, S., (2021). The Relation of miRNA21/155 levels with acute side effects and treatment response in stage III NSCLC. RADIOTHERAPY AND ONCOLOGY .

Gumustepe, E. Et Al. "The Relation of miRNA21/155 levels with acute side effects and treatment response in stage III NSCLC," RADIOTHERAPY AND ONCOLOGY , 2021

Gumustepe, E. Et Al. "The Relation of miRNA21/155 levels with acute side effects and treatment response in stage III NSCLC." RADIOTHERAPY AND ONCOLOGY , 2021

Gumustepe, E. Et Al. (2021) . "The Relation of miRNA21/155 levels with acute side effects and treatment response in stage III NSCLC." RADIOTHERAPY AND ONCOLOGY .

@article{article, author={E. Gumustepe Et Al. }, title={The Relation of miRNA21/155 levels with acute side effects and treatment response in stage III NSCLC}, journal={RADIOTHERAPY AND ONCOLOGY}, year=2021}